A Qualitative Evaluation of Adverse Drug Reaction Reporting System in Pakistan: Findings from the Nurses' Perspective.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 04 2020
Historique:
received: 01 04 2020
revised: 15 04 2020
accepted: 22 04 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 2 10 2020
Statut: epublish

Résumé

The contribution of all key healthcare professionals is vital to promote an efficient adverse drug reaction (ADR) reporting system. In this context, nurses are important as they are in a better position to observe a patient's response regarding the drug therapy and to report an ADR. The aim of the study was to explore the perspectives of nurses about ADR reporting system in Lahore, Pakistan. A total of 21 nurses were interviewed. The thematic content analysis of the qualitative interviews yielded six major themes and eight subthemes. Major themes included: (1) Knowledge about the concept of the medication safety & the ADR; (2) Knowledge regarding pharmacovigilance activities; (3) Willingness to report; (4) Practices related to the ADR reporting; (5) Barriers to the ADR reporting; (6) Facilitators to the ADR reporting. The majority of the nurses were aware of medicine safety and ADRs, but in many cases, they were unable to report these ADRs. The study pointed out considerable concerns regarding the knowledge and practices of nurses about pharmacovigilance activities in their workplace, mainly due to increased workload, due to the absence of a reporting system and legal liability. The main challenges turned out to be the lack of knowledge and training, as well as the implementation of guidelines. Based on the findings, it is suggested that outcome of this study can serve as a guide to design policies that support ADR reporting by nurses in Pakistan.

Identifiants

pubmed: 32349339
pii: ijerph17093039
doi: 10.3390/ijerph17093039
pmc: PMC7246579
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Med Educ. 2018 Jul 3;18(1):158
pubmed: 29970054
Lancet. 2003 Apr 19;361(9366):1347-8
pubmed: 12711472
Anaesthesia. 2016 Nov;71(11):1332-1340
pubmed: 27734483
Iran J Nurs Midwifery Res. 2012 Jan;17(1):21-5
pubmed: 23492864
J Nurs Manag. 2010 Oct;18(7):853-61
pubmed: 20946221
Scand J Prim Health Care. 2016;34(1):37-45
pubmed: 26846298
Int J Nurs Stud. 2014 Aug;51(8):1114-22
pubmed: 24418106
J Nurs Scholarsh. 2011 Jun;43(2):171-80
pubmed: 21605321
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):597-602
pubmed: 22337264
Am J Health Syst Pharm. 2007 Jul 1;64(13):1422-6
pubmed: 17592009
Stat Med. 1993 Dec 30;12(24):2383-93
pubmed: 8134741
J Adv Nurs. 2010 May;66(5):1072-9
pubmed: 20337787
Can J Nurs Res. 2012 Sep;44(3):128-49
pubmed: 23156195
Ann Ist Super Sanita. 2015;51(4):277-83
pubmed: 26783213
J Nurs Scholarsh. 2010 Jun;42(2):156-65
pubmed: 20618600
Int J Risk Saf Med. 2012;24(2):81-94
pubmed: 22751190
J Am Geriatr Soc. 2009 Feb;57(2):266-72
pubmed: 19170782
J Nurses Staff Dev. 2011 Jan-Feb;27(1):E1-5; quiz E6-7
pubmed: 21263270
J Nurs Scholarsh. 2007;39(1):82-7
pubmed: 17393971
J Clin Pharm Ther. 2016 Aug;41(4):414-8
pubmed: 27255463
Nurs Times. 2005 Aug 16-22;101(33):32-4
pubmed: 16130498
North Clin Istanb. 2015 Jan 24;1(3):147-152
pubmed: 28058321
J Nurs Manag. 2016 Apr;24(3):409-16
pubmed: 26481698
Eur J Clin Pharmacol. 2007 Jun;63(6):613-8
pubmed: 17404719
Int J Nurs Educ Scholarsh. 2004;1:Article27
pubmed: 16646893
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Iran J Nurs Midwifery Res. 2014 May;19(3):315-22
pubmed: 24949073
Saudi Pharm J. 2018 May;26(4):453-461
pubmed: 29844715
Int J Nurs Pract. 2009 Dec;15(6):543-52
pubmed: 19958409
J Patient Saf. 2010 Dec;6(4):226-32
pubmed: 21099551
Iran J Nurs Midwifery Res. 2014 Jan;19(1):101-6
pubmed: 24554968
Iran J Pharm Res. 2010 Spring;9(2):199-206
pubmed: 24363728
J Pak Med Assoc. 2015 Aug;65(8):882-4
pubmed: 26228337
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
J Patient Saf. 2017 Jun 30;:
pubmed: 28671909
J Pharm Policy Pract. 2018 Jul 19;11:16
pubmed: 30034811
Pharmacoepidemiol Drug Saf. 2007 May;16(5):532-7
pubmed: 17072915
J Pharm Policy Pract. 2019 May 21;12:14
pubmed: 31139421
Springerplus. 2016 Oct 12;5(1):1778
pubmed: 27795920

Auteurs

Rabia Hussain (R)

Department of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia.

Mohamed Azmi Hassali (MA)

Department of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia.

Anees Ur Rehman (A)

Department of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia.

Jaya Muneswarao (J)

Department of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia.

Muhammad Atif (M)

Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur 63100, Pakistan.

Zaheer-Ud-Din Babar (ZU)

Department of Pharmacy, University of Huddersfield, Huddersfield HD1 3DH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH